Detecting factor XIa in immune globulin products: Commutability of international reference materials for traditional and global hemostasis assays

Yideng Liang; Joseph W. Jackson; Samuel A. Woodle; Stepan S. Surov; Leonid A. Parunov; Dorothy E. Scott; Mark Weinstein; Timothy K. Lee; Mikhail V. Ovanesov

doi:10.1002/rth2.12467

journal article Open Access Jan 01, 2021

Detecting factor XIa in immune globulin products: Commutability of international reference materials for traditional and global hemostasis assays

Yideng Liang Joseph W. Jackson

Samuel A. Woodle Stepan S. Surov Leonid A. Parunov

Dorothy E. Scott Mark Weinstein Timothy K. Lee Mikhail V. Ovanesov

Research and Practice in Thrombosis and Haemostasis Vol. 5 No. 1 pp. 211-222 · Elsevier BV

View at Publisher Save 10.1002/rth2.12467

Topics

No keywords indexed for this article. Browse by subject →

References

27

[1]

Al‐Horani "Factor XIa inhibitors: a review of the patent literature" Expert Opin Ther Pat (2016) 10.1517/13543776.2016.1154045

[2]

Mohammed "An update on factor XI structure and function" Thromb Res (2018) 10.1016/j.thromres.2017.10.008

[3]

Wang "Effects of factor XI deficiency on ferric chloride‐induced vena cava thrombosis in mice" J Thromb Haemost (2006) 10.1111/j.1538-7836.2006.02093.x

[4]

Salomon "Reduced incidence of ischemic stroke in patients with severe factor XI deficiency" Blood (2008) 10.1182/blood-2007-10-120139

[5]

Salomon "Patients with severe factor XI deficiency have a reduced incidence of deep‐vein thrombosis" Thromb Haemost (2011) 10.1160/th10-05-0307

[6]

Yang "Elevated factor XI activity levels are associated with an increased odds ratio for cerebrovascular events" Am J Clin Pathol (2006) 10.1309/qc259f09unmkvp0r

[7]

Woodruff "Fatal thrombotic events during treatment of autoimmune thrombocytopenia with intravenous immunoglobulin in elderly patients" Lancet (1986) 10.1016/s0140-6736(86)92511-0

[8]

Doggen "Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: opposite and synergistic effects of factors XI and XII" Blood (2006) 10.1182/blood-2005-12-023697

[9]

Suri "Novel hemostatic factor levels and risk of ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study" Cerebrovasc Dis (2010) 10.1159/000297966

[10]

Bolton‐Maggs "Factor XI deficiency" Baillieres Clin Haematol (1996) 10.1016/s0950-3536(96)80068-0

[11]

Daniel "Immune globulins and thrombotic adverse events as recorded in a large administrative database in 2008 through 2010" Transfusion (2012) 10.1111/j.1537-2995.2012.03589.x

[12]

Menis "Hyperimmune globulins and same‐day thrombotic adverse events as recorded in a large healthcare database during 2008–2011" Am J Hematol (2013) 10.1002/ajh.23559

[13]

Gray EWH, Hogwood J, Rigsby P. Evaluation of the proposed WHO 1 st Reference Reagent for Activated Blood Coagulation Factor XI (FXIa), HumanOctober 2012. Available from: http://apps.who.int/iris/bitstream/10665/78047/1/WHO_BS_2012.2206_eng.pdf

[14]

Ekezue "Clotting factor product administration and same‐day occurrence of thrombotic events, as recorded in a large healthcare database during 2008–2013" J Thromb Haemost (2015) 10.1111/jth.13155

[15]

Gray (2014)

[16]

Butenas "Ultrasensitive fluorogenic substrates for serine proteases" Thromb Haemost (1997) 10.1055/s-0038-1657714

[17]

Butenas "Factor XIa and tissue factor activity in patients with coronary artery disease" Thromb Haemost (2008) 10.1160/th07-08-0499

[18]

Sridhar "Immune globulins and same‐day thrombotic events as recorded in a large health care database during 2008 to 2012" Transfusion (2014) 10.1111/trf.12663

[19]

Liang "Correction of microplate location effects improves performance of the thrombin generation test" Thromb J (2013) 10.1186/1477-9560-11-12

[20]

Woodle "Determining the impact of instrument variation and automated software algorithms on the TGT in hemophilia and normalized plasma" Thromb Res (2013) 10.1016/j.thromres.2013.07.018

[21]

Etscheid "Identification of kallikrein and FXIa as impurities in therapeutic immunoglobulins: implications for the safety and control of intravenous blood products" Vox Sang (2012) 10.1111/j.1423-0410.2011.01502.x

[22]

Parunov "Can the diagnostic reliability of the thrombin generation test as a global haemostasis assay be improved? The impact of calcium chloride concentration" Haemophilia (2017) 10.1111/hae.13174

[23]

Loeffen "Increased factor XIa levels in patients with a first acute myocardial infarction: the introduction of a new thrombin generation based factor XIa assay" Thromb Res (2014) 10.1016/j.thromres.2014.09.015

[24]

Undas "Activated factor XI and tissue factor in inflammatory bowel disease" Inflamm Bowel Dis (2010) 10.1002/ibd.21206

[25]

Wong "A small‐molecule factor XIa inhibitor produces antithrombotic efficacy with minimal bleeding time prolongation in rabbits" J Thromb Thrombolysis (2011) 10.1007/s11239-011-0599-0

[26]

Zhang "Inhibition of the intrinsic coagulation pathway factor XI by antisense oligonucleotides: a novel antithrombotic strategy with lowered bleeding risk" Blood (2010) 10.1182/blood-2010-04-277798

[27]

Al‐Horani "Factor XI(a) inhibitors for thrombosis: an updated patent review (2016‐present)" Expert Opin Ther Pat (2020) 10.1080/13543776.2020.1705783

Metrics

5

Citations

27

References

Details

Published: Jan 01, 2021
Vol/Issue: 5(1)
Pages: 211-222
License: View

Authors

Funding

Oak Ridge Institute for Science and Education

Cite This Article

Yideng Liang, Joseph W. Jackson, Samuel A. Woodle, et al. (2021). Detecting factor XIa in immune globulin products: Commutability of international reference materials for traditional and global hemostasis assays. Research and Practice in Thrombosis and Haemostasis, 5(1), 211-222. https://doi.org/10.1002/rth2.12467

Detecting factor XIa in immune globulin products: Commutability of international reference materials for traditional and global hemostasis assays

You May Also Like